Cargando…
Correction to: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
Autores principales: | Zimmerman, Andrew W., Singh, Kanwaljit, Connors, Susan L., Liu, Hua, Panjwani, Anita A., Lee, Li‑Ching, Diggins, Eileen, Foley, Ann, Melnyk, Stepan, Singh, Indrapal N., Jill James, S., Frye, Richard E., Fahey, Jed W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207600/ https://www.ncbi.nlm.nih.gov/pubmed/34134777 http://dx.doi.org/10.1186/s13229-021-00451-9 |
Ejemplares similares
-
Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
por: Zimmerman, Andrew W., et al.
Publicado: (2021) -
Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder
por: Liu, Hua, et al.
Publicado: (2020) -
Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study
por: Lynch, Rhoda, et al.
Publicado: (2017) -
Developmental regression and mitochondrial function in children with autism
por: Singh, Kanwaljit, et al.
Publicado: (2020) -
Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
por: Bent, Stephen, et al.
Publicado: (2018)